Table 3.

Primary and secondary outcomes by trial arm

	LMA (intervention) n=24 mean (SD) range	Face mask (comparator) n=25 mean (SD) range	p Value	Effect of the intervention Mean ratio (95% CI)
Primary outcome			0.005	0.70 (0.56 to 0.89)
Time to spontaneous breathing (s)	153 (59) 45–300	216 (92) 65–395
	n (%)	n (%)		OR (95% CI)
Secondary outcomes
Admission to neonatal unit (first 48 hours)	5 (21)	8 (32)	0.52	0.56 (0.12 to 2.42)
Neonatal encephalopathy	0	2 (8)	0.49	0.00 (0.00 to 5.51)
Death within 48 hours	0	1 (4)	0.99	0.00 (0.00 to 40.63)
Adverse effects (vomiting, bleeding or laryngospasm)	0	0	0.99	Not applicable

LMA, laryngeal mask airway.